/PRNewswire/ -- 律師事務所 Robbins Geller Rudman &amp; Dowd LLP 宣佈，在 2025 年 2 月 5 日至 2025 年 7 月 23 日（包括這兩個日期）期間購買或獲得 Molina Healthcare, Inc. (NYSE: MOH) 證券的投資者，有直到 2025 年 12 月 2 日的時間申請成為 Molina 集體訴訟的首席原告。該案件標題為 Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.)，指控 Molina Healthcare 及其部分高管違反了 1934 年證券交易法。
如果您遭受了重大損失並希望擔任 Molina Healthcare 集體訴訟的首席原告，請在此提供您的信息：
https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
您也可以通過撥打 800/449-4900 或發送電子郵件至 [email protected] 聯繫 Robbins Geller 的律師 J.C. Sanchez 或 Jennifer N. Caringal。
案件指控：Molina Healthcare 為低收入家庭和個人提供管理醫療服務，涵蓋 Medicaid 和 Medicare 項目以及州保險市場。
Molina Healthcare 集體訴訟指控被告在整個訴訟期間未能披露：(i) 關於 Molina Healthcare 的 “醫療成本趨勢假設” 的重要不利事實；(ii) Molina Healthcare 正在經歷 “保費率與醫療成本趨勢之間的失衡”；(iii) Molina Healthcare 的短期增長依賴於缺乏 “行為健康、藥房以及住院和門診服務的使用”；以及 (iv) 因此，Molina Healthcare 對 2025 財年的財務指引很可能會大幅下調。
Molina Healthcare 集體訴訟進一步指控，2025 年 7 月 7 日，Molina Healthcare 披露了 2025 年第二季度調整後每股收益約為 5.50 美元，低於其先前預期，原因是 “三個業務線的醫療成本壓力”。Molina Healthcare 還披露 “預計這些醫療成本壓力將持續到下半年”，並在中點上將預期調整後每股收益指引下調 10.2%，並且正在經歷來自 “保費率與醫療成本趨勢之間的失衡的短期收益壓力，該失衡最近加劇”，投訴中指出。根據投訴，這一消息導致 Molina Healthcare 股票價格下跌。
然後，Molina Healthcare 集體訴訟指控，2025 年 7 月 23 日，Molina Healthcare 報告了截至 2025 年 6 月 30 日的第二季度財務結果，並進一步下調了 2025 年全年的收益指引。在此過程中，Molina Healthcare 披露 “2025 年第二季度的 GAAP 淨收入為每稀釋股 4.75 美元，同比下降 8%”，並且 “現在預計 2025 年全年的調整後每股收益不低於 19.00 美元”，Molina Healthcare 集體訴訟稱。Molina Healthcare 據稱將其結果和全年展望歸因於 “具有挑戰性的醫療成本趨勢環境”，包括 “行為健康、藥房以及住院和門診服務的使用”。根據投訴，這一消息導致 Molina Healthcare 股票價格下跌近 17%。
首席原告流程：1995 年《私人證券訴訟改革法》允許在集體訴訟期間購買或獲得 Molina Healthcare 證券的任何投資者申請成為 Molina Healthcare 集體訴訟的首席原告。首席原告通常是尋求救濟的潛在集體中財務利益最大的動議者，同時也是潛在集體的典型和適當代表。首席原告代表所有其他集體成員指導 Molina Healthcare 集體訴訟。首席原告可以選擇其選擇的律師事務所來進行 Molina Healthcare 集體訴訟。投資者分享任何潛在未來賠償的能力並不依賴於擔任 Molina Healthcare 集體訴訟的首席原告。
關於 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球領先的律師事務所之一，代表投資者進行證券欺詐和股東訴訟。我們的事務所過去五年中有四年在 ISS 證券集體訴訟服務排名中被評為第一，因為為投資者爭取到最多的貨幣救濟。在 2024 年，我們為證券相關集體訴訟案件為投資者追回了超過 25 億美元的賠償——根據 ISS，這一金額超過了接下來五家律師事務所的總和。Robbins Geller 擁有 200 名律師，設有 10 個辦公室，是全球最大的原告律師事務所之一，事務所的律師獲得了歷史上許多最大的證券集體訴訟賠償，包括最大的一筆——72 億美元——在 In re Enron Corp. Sec. Litig. 案件中。有關更多信息，請訪問以下頁面：
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
過去的結果並不保證未來的結果。
服務可能由我們任何辦公室的律師提供。
聯繫方式：
Robbins Geller Rudman &amp; Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected]
來源 Robbins Geller Rudman &amp; Dowd LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2"/>

Molina醫療

Robbins Geller Rudman & Dowd LLP 宣佈，Molina Healthcare, Inc.（紐約證券交易所代碼：MOH）的投資者如果在 2025 年 2 月 5 日至 2025 年 7 月 23 日期間遭受重大損失，可以尋求領導集體訴訟。該訴訟指控違反了 1934 年證券交易法，提到關於 Molina 財務健康和醫療成本趨勢的未披露不利事實。在令人失望的財報發佈後，Molina 的股價大幅下跌。感興趣的投資者必須在 2025 年 12 月 2 日之前申請，以便被考慮作為主要原告

, /PRNewswire/ -- The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the &#34;Class Period&#34;), have until December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.), the Molina Healthcare class action lawsuit charges Molina Healthcare and certain of Molina Healthcare's top executives with violations of the Securities Exchange Act of 1934.
<div class="lb-trans">/PRNewswire/ -- 律師事務所 Robbins Geller Rudman &amp; Dowd LLP 宣佈，在 2025 年 2 月 5 日至 2025 年 7 月 23 日（包括這兩個日期）期間購買或獲得 Molina Healthcare, Inc. (NYSE: MOH) 證券的投資者，有直到 2025 年 12 月 2 日的時間申請成為 Molina 集體訴訟的首席原告。該案件標題為 Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.)，指控 Molina Healthcare 及其部分高管違反了 1934 年證券交易法。
</div>If you suffered substantial losses and wish to serve as lead plaintiff of the Molina Healthcare class action lawsuit, please provide your information here:
<div class="lb-trans">如果您遭受了重大損失並希望擔任 Molina Healthcare 集體訴訟的首席原告，請在此提供您的信息：
</div>https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
<div class="lb-trans">https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
</div>You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].
<div class="lb-trans">您也可以通過撥打 800/449-4900 或發送電子郵件至 [email protected] 聯繫 Robbins Geller 的律師 J.C. Sanchez 或 Jennifer N. Caringal。
</div>CASE ALLEGATIONS: Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
<div class="lb-trans">案件指控：Molina Healthcare 為低收入家庭和個人提供管理醫療服務，涵蓋 Medicaid 和 Medicare 項目以及州保險市場。
</div>The Molina Healthcare class action lawsuit alleges that defendants throughout the Class Period failed to disclose: (i) material, adverse facts concerning Molina Healthcare's &#34;medical cost trend assumptions&#34;; (ii) that Molina Healthcare was experiencing a &#34;dislocation between premium rates and medical cost trend&#34;; (iii) that Molina Healthcare's near term growth was dependent on a lack of &#34;utilization of behavioral health, pharmacy, and inpatient and outpatient services&#34;; and (iv) as a result, Molina Healthcare's financial guidance for fiscal year 2025 was substantially likely to be cut.
<div class="lb-trans">Molina Healthcare 集體訴訟指控被告在整個訴訟期間未能披露：(i) 關於 Molina Healthcare 的 “醫療成本趨勢假設” 的重要不利事實；(ii) Molina Healthcare 正在經歷 “保費率與醫療成本趨勢之間的失衡”；(iii) Molina Healthcare 的短期增長依賴於缺乏 “行為健康、藥房以及住院和門診服務的使用”；以及 (iv) 因此，Molina Healthcare 對 2025 財年的財務指引很可能會大幅下調。
</div>The Molina Healthcare class action lawsuit further alleges that on July 7, 2025, Molina Healthcare revealed second quarter 2025 adjusted earnings of approximately $5.50 per share, which was &#34;below its prior expectations&#34; due to &#34;medical cost pressures in all three lines of business.&#34; Molina Healthcare also disclosed that it &#34;expects these medical cost pressures to continue into the second half of the year,&#34; cut guidance for expected adjusted earnings per share 10.2% at the midpoint, and that it was experiencing a &#34;short-term earnings pressure&#34; from a &#34;dislocation between premium rates and medical cost trend which has recently accelerated,&#34; the complaint alleges. On this news, the price of Molina Healthcare stock fell, according to the complaint.
<div class="lb-trans">Molina Healthcare 集體訴訟進一步指控，2025 年 7 月 7 日，Molina Healthcare 披露了 2025 年第二季度調整後每股收益約為 5.50 美元，低於其先前預期，原因是 “三個業務線的醫療成本壓力”。Molina Healthcare 還披露 “預計這些醫療成本壓力將持續到下半年”，並在中點上將預期調整後每股收益指引下調 10.2%，並且正在經歷來自 “保費率與醫療成本趨勢之間的失衡的短期收益壓力，該失衡最近加劇”，投訴中指出。根據投訴，這一消息導致 Molina Healthcare 股票價格下跌。
</div>Then, the Molina Healthcare class action lawsuit alleges that on July 23, 2025 Molina Healthcare reported its financial results for the second quarter ended June 30, 2025 and further cut its full-year 2025 earnings guidance. In doing so, Molina Healthcare revealed that &#34;GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year&#34; and it &#34;now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share,&#34; the Molina Healthcare class action alleges. Molina Healthcare allegedly attributed its results and full year outlook to a &#34;challenging medical cost trend environment,&#34; including &#34;utilization of behavioral health, pharmacy, and inpatient and outpatient services.&#34; On this news, the price of Molina Healthcare stock fell nearly 17%, according to the complaint.
<div class="lb-trans">然後，Molina Healthcare 集體訴訟指控，2025 年 7 月 23 日，Molina Healthcare 報告了截至 2025 年 6 月 30 日的第二季度財務結果，並進一步下調了 2025 年全年的收益指引。在此過程中，Molina Healthcare 披露 “2025 年第二季度的 GAAP 淨收入為每稀釋股 4.75 美元，同比下降 8%”，並且 “現在預計 2025 年全年的調整後每股收益不低於 19.00 美元”，Molina Healthcare 集體訴訟稱。Molina Healthcare 據稱將其結果和全年展望歸因於 “具有挑戰性的醫療成本趨勢環境”，包括 “行為健康、藥房以及住院和門診服務的使用”。根據投訴，這一消息導致 Molina Healthcare 股票價格下跌近 17%。
</div>THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Molina Healthcare securities during the Class Period to seek appointment as lead plaintiff in the Molina Healthcare class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Molina Healthcare class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Molina Healthcare class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Molina Healthcare class action lawsuit.
<div class="lb-trans">首席原告流程：1995 年《私人證券訴訟改革法》允許在集體訴訟期間購買或獲得 Molina Healthcare 證券的任何投資者申請成為 Molina Healthcare 集體訴訟的首席原告。首席原告通常是尋求救濟的潛在集體中財務利益最大的動議者，同時也是潛在集體的典型和適當代表。首席原告代表所有其他集體成員指導 Molina Healthcare 集體訴訟。首席原告可以選擇其選擇的律師事務所來進行 Molina Healthcare 集體訴訟。投資者分享任何潛在未來賠償的能力並不依賴於擔任 Molina Healthcare 集體訴訟的首席原告。
</div>ABOUT ROBBINS GELLER: Robbins Geller Rudman &amp; Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
<div class="lb-trans">關於 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球領先的律師事務所之一，代表投資者進行證券欺詐和股東訴訟。我們的事務所過去五年中有四年在 ISS 證券集體訴訟服務排名中被評為第一，因為為投資者爭取到最多的貨幣救濟。在 2024 年，我們為證券相關集體訴訟案件為投資者追回了超過 25 億美元的賠償——根據 ISS，這一金額超過了接下來五家律師事務所的總和。Robbins Geller 擁有 200 名律師，設有 10 個辦公室，是全球最大的原告律師事務所之一，事務所的律師獲得了歷史上許多最大的證券集體訴訟賠償，包括最大的一筆——72 億美元——在 In re Enron Corp. Sec. Litig. 案件中。有關更多信息，請訪問以下頁面：
</div>https://www.rgrdlaw.com/services-litigation-securities-fraud.html
<div class="lb-trans">https://www.rgrdlaw.com/services-litigation-securities-fraud.html
</div>Past results do not guarantee future outcomes.
<div class="lb-trans">過去的結果並不保證未來的結果。
</div>Services may be performed by attorneys in any of our offices.
<div class="lb-trans">服務可能由我們任何辦公室的律師提供。
</div>Contact:
<div class="lb-trans">聯繫方式：
</div>Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">Robbins Geller Rudman &amp; Dowd LLP
</div>J.C. Sanchez, Jennifer N. Caringal
<div class="lb-trans">J.C. Sanchez, Jennifer N. Caringal
</div>655 W. Broadway, Suite 1900, San Diego, CA 92101
<div class="lb-trans">655 W. Broadway, Suite 1900, San Diego, CA 92101
</div>800-449-4900
<div class="lb-trans">800-449-4900
</div>[email protected]
<div class="lb-trans">[email protected]
</div>SOURCE Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">來源 Robbins Geller Rudman &amp; Dowd LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA91726&amp;Transmission_Id=202510070550PR_NEWS_USPR_____LA91726&amp;DateId=20251007"/>

05:50 ET
			
			
				MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MOH 投資者通知：Robbins Geller Rudman & Dowd LLP 宣佈，Molina Healthcare, Inc.的投資者如果遭受重大損失，有機會主導集體訴訟